Profil
Rikin Mehta is the founder of Lactiga, Inc. He is currently working as a Director at Licentiam, Inc.
Aktive Positionen von Rikin Mehta
| Unternehmen | Position | Beginn |
|---|---|---|
Licentiam, Inc.
 Licentiam, Inc. Information Technology ServicesTechnology Services Licentiam, Inc. provides information technology services. The firm engages in transforming the fragmented health and medical regulatory environment into a dynamic and integrated network, connecting practitioners and licensing boards, enabling portability and telehealth. The company was founded by Mark Vargas and Jason Reed and is headquartered in Woodbridge, NJ. | Direktor/Vorstandsmitglied | - |
Lactiga, Inc.
 Lactiga, Inc. BiotechnologyHealth Technology Lactiga, Inc. operates as bio Therapeutics Company, which develops biologic to prevent mucosal infections. Its product, LCTG-001, is designed for patients with Primary Immunodeficiency Diseases (PID), including Selective IgA Deficiency (SIgAD) and Common Variable Immunodeficiency (CVID). The company was founded by Viraj Mane and Rikin Mehta and is headquartered in Toronto, Canada. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Licentiam, Inc.
Licentiam, Inc. Information Technology ServicesTechnology Services Licentiam, Inc. provides information technology services. The firm engages in transforming the fragmented health and medical regulatory environment into a dynamic and integrated network, connecting practitioners and licensing boards, enabling portability and telehealth. The company was founded by Mark Vargas and Jason Reed and is headquartered in Woodbridge, NJ. | Technology Services |
Lactiga, Inc.
Lactiga, Inc. BiotechnologyHealth Technology Lactiga, Inc. operates as bio Therapeutics Company, which develops biologic to prevent mucosal infections. Its product, LCTG-001, is designed for patients with Primary Immunodeficiency Diseases (PID), including Selective IgA Deficiency (SIgAD) and Common Variable Immunodeficiency (CVID). The company was founded by Viraj Mane and Rikin Mehta and is headquartered in Toronto, Canada. | Health Technology |
